5-fluorouracil | CAS:51-21-8

We serve 5-fluorouracil CAS:51-21-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-fluorouracil

Chemical Name:5-fluorouracil
CAS.NO:51-21-8
Synonyms:5-fluoropyrimidine-2,4-dione
5-Fluoro Uracil
Molecular Formula:C4H3FN2O2
Molecular Weight:130.07700
 
Physical and Chemical Properties:
Density:1.53
Melting point:282-286ºC
Boiling point:190-200ºC
Flash point:196.5ºC
Index of Refraction:1.542
 
Specification:
Appearance:White or off-white crystalline powder
Purity(HPLC):≥99.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.1%
Heavy metal:≤20ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:5-Fluoro Uracil is is an DNA/RNA synthesis inhibitor. Also used to synthesize 5-fluorocytosine. It is used as a potent antitumor agent since it interrupts nucleotide synthetic by inhibiting thymidylate synthase.



Contact us for information like 5-Fluorouracil chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Fluoro Uracil physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-fluoropyrimidine-2,4-dione Use and application,5-fluoropyrimidine-2,4-dione technical grade,usp/ep/jp grade.


Related News: Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.3,4-Difluorobenzonitrile manufacturer Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.2,2'-Dihydroxy-4,4'-dimethoxybenzophenone supplier Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads.Dimethyl nonanedioate vendor Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads.The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.